Core Viewpoint - The Hong Kong stock market experienced volatility and divergence on February 25, with the technology sector opening high but closing lower, indicating mixed performance across different indices [1]. Market Performance - The CSI Hong Kong Stock Connect Consumer Theme Index rose by 0.1%, while the Hang Seng Stock Connect New Economy Index and the CSI Hong Kong Stock Connect Medical and Health Comprehensive Index both fell by 0.1%. The Hang Seng Technology Index and the CSI Hong Kong Stock Connect Internet Index declined by 0.2% [1]. - The net inflow for the E Fund Hang Seng Technology ETF (513010) reached 700 million yuan, and the E Fund Hong Kong Stock Connect Internet ETF (513040) saw a net inflow of 180 million yuan on the same day [1]. Sector Analysis - According to Huatai Securities, the divergence in the Hong Kong stock market intensified during the Spring Festival, with AI new forces and internet giants showing opposite trends. Despite positive consumer data, it did not significantly boost sector performance, with gains concentrated in technology and cyclical industries [1]. - The report suggests that investors should be cautious of the volatility risks associated with index adjustments and individual stock movements in the short term. In the medium term, technology and cyclical materials remain clear investment themes [1].

Core Viewpoint - The Hong Kong stock market experienced fluctuations, with various indices showing declines, indicating a divergence in market performance among sectors, particularly between AI and internet giants, despite positive consumer data [1]. Group 1: Market Performance - The China Securities Hong Kong Stock Connect Consumer Theme Index fell by 1.3% [1] - The Hang Seng Technology Index decreased by 2.1% [1] - The Hang Seng Hong Kong Stock Connect New Economy Index dropped by 2.5% [1] - The China Securities Hong Kong Stock Connect Medical and Health Comprehensive Index declined by 3.1% [1] - The China Securities Hong Kong Stock Connect Internet Index fell by 3.3% [1] Group 2: Fund Flows - The net inflow for the E Fund Hang Seng Technology ETF (513010) reached 3.61 billion yuan in the last month [1] - The net inflow for the E Fund Hong Kong Stock Connect Internet ETF (513040) was 1.49 billion yuan in the last month [1] Group 3: Sector Insights - The report from Huatai Securities indicates increased market differentiation during the Spring Festival, with AI new forces and internet giants showing divergent trends [1] - Despite bright consumer data, there was no significant uplift in sector performance, with gains concentrated in technology and cyclical industries [1] - The short-term outlook suggests investors should be cautious of volatility risks associated with index adjustments and individual stock movements [1] - The mid-term strategy highlights technology and cyclical materials as clear main lines for investment [1]

Core Viewpoint - The pharmaceutical industry is experiencing growth due to persistent human demand and unmet needs, alongside increased R&D investments by companies, marking the transition to an "innovation-driven" revenue era in China [1]. Index Performance - The CSI Hong Kong Stock Connect Healthcare Comprehensive Index rose by 3.3% this week, while the Hang Seng Hong Kong Stock Connect Innovative Drug Index increased by 2.5%. Conversely, the CSI Innovative Drug Industry Index and the CSI Biotech Theme Index both declined by 0.2%, and the CSI 300 Healthcare Index fell by 0.6% [1][2]. - Year-to-date performance shows the CSI Hong Kong Stock Connect Healthcare Comprehensive Index up by 10.8%, while the CSI Innovative Drug Industry Index is down by 0.1% [7]. Valuation Metrics - The rolling P/E ratios for the indices are as follows: Hang Seng Hong Kong Stock Connect Innovative Drug Index at 55.6x, CSI Hong Kong Stock Connect Healthcare Comprehensive Index at 33.4x, CSI Innovative Drug Industry Index at 51.3x, CSI Biotech Theme Index at 54.1x, and CSI 300 Healthcare Index at 29.8x [2][6]. - As of July 2023, the valuation percentiles indicate that the Hang Seng Hong Kong Stock Connect Innovative Drug Index is at 53.0%, the CSI Hong Kong Stock Connect Healthcare Comprehensive Index at 75.2%, and the CSI Innovative Drug Industry Index at 61.5% [2]. Industry Trends - The pharmaceutical sector in China is becoming a significant player in global innovative drug development, with increasing enthusiasm for overseas licensing [1]. - The market is characterized by a focus on leading companies in innovative drug research, development, and production, with a concentration on healthcare industry stocks [3].

Core Viewpoint - The Hong Kong stock market experienced fluctuations this week, with pharmaceutical stocks leading the gains, while the technology sector showed mixed results. The healthcare index rose by 3.3%, and the new economy index increased by 1.0% [1]. Index Performance - The performance of various indices this week is as follows: - CSI Hong Kong Stock Connect Healthcare Index: +3.3% - Hang Seng Hong Kong Stock Connect New Economy Index: +1.0% - CSI Hong Kong Stock Connect Consumer Theme Index: +0.8% - Hang Seng Technology Index: +0.3% - CSI Hong Kong Stock Connect Internet Index: -0.1% [2][1]. - The net inflows for ETFs this week were: - Hang Seng Technology ETF: 910 million - Hong Kong Stock Connect Internet ETF: 250 million [1]. Future Outlook - According to Guotai Junan Securities, by 2026, AI applications are expected to evolve from usable to highly effective, with diverse business models emerging. AI applications are projected to become a core theme in the AI industry market, particularly for internet platform companies with high capital expenditure and mature products, as well as companies in healthcare, finance, and education sectors focusing on vertical product development [1].

Group 1 - The core indices related to Hong Kong stocks showed positive performance, with the CSI Hong Kong Stock Connect Internet Index and the Hang Seng Hong Kong Stock Connect New Economy Index both rising by 1.1%, while the Hang Seng Technology Index increased by 0.9% and the CSI Hong Kong Stock Connect Healthcare Index rose by 0.7%. However, the CSI Hong Kong Stock Connect Consumer Theme Index declined by 0.5% [1] - The E Fund Hang Seng Technology ETF (513010) has seen a net inflow of funds for seven consecutive trading days, totaling 2.3 billion yuan [1] Group 2 - The Hang Seng Hong Kong Stock Connect New Economy Index consists of 50 stocks from the "new economy" sectors with the largest market capitalization, primarily including information technology, consumer discretionary, and healthcare [2] - The rolling price-to-earnings (P/E) ratio for the Hang Seng Hong Kong Stock Connect New Economy Index is 24.4 times, with a valuation percentile of 51.3% since its inception in 2018 [2] - The Hang Seng Technology Index is composed of 30 stocks highly related to technology, with over 90% of its composition from information technology and consumer discretionary sectors. Its rolling P/E ratio is 22.5 times, with a valuation percentile of 26.2% since its launch in 2020 [2] - The CSI Hong Kong Stock Connect Healthcare Index includes 50 liquid and high-value stocks in the healthcare sector, with a rolling P/E ratio of 33.4 times and a valuation percentile of 53.1% since its inception in 2017 [2] - The CSI Hong Kong Stock Connect Internet Index consists of 30 leading internet companies, with a rolling P/E ratio of 24.1 times and a valuation percentile of 21.4% since its launch in 2021 [2] - The CSI Hong Kong Stock Connect Consumer Theme Index is made up of 50 liquid and large-cap consumer stocks, with over 65% in consumer discretionary. Its rolling P/E ratio is 18.6 times, with a valuation percentile of 4.6% since its inception in 2020 [3]

Group 1 - The Hang Seng Hong Kong Stock Connect Innovative Drug Index rose by 2.6%, while the China Securities Hong Kong Stock Connect Pharmaceutical and Health Comprehensive Index increased by 2.4% [1] - The China Securities Innovative Drug Industry Index and the China Securities Biotechnology Theme Index saw increases of 1.4% and 1.0% respectively, with the CSI 300 Pharmaceutical and Health Index rising by 0.9% [1] - Huachuang Securities stated that the fundamental reason for the pharmaceutical industry's ability to reach new highs despite ongoing challenges is the continuous demand for pharmaceuticals and the increasing number of unmet needs, along with pharmaceutical companies' ongoing investment in R&D to meet these demands [1] - China has become a significant player in global innovative drug R&D, with overseas licensing activity continuing to rise year after year, marking the pharmaceutical industry’s entry into a revenue era driven by innovation [1]

Core Viewpoint - The Hong Kong stock market shows resilience with various indices experiencing gains, indicating a stabilization in earnings expectations despite previous downward adjustments in EPS forecasts for the Hang Seng Technology Index [1]. Group 1: Index Performance - The CSI Hong Kong Stock Connect Healthcare Index rose by 2.4% [1] - The CSI Hong Kong Stock Connect Consumer Theme Index increased by 1.1% [1] - The Hang Seng Hong Kong Stock Connect New Economy Index gained 0.8% [1] - The Hang Seng Technology Index saw a rise of 0.6% [1] - The CSI Hong Kong Stock Connect Internet Index experienced a slight increase of 0.1% [1] Group 2: Fund Inflows - The E Fund Hang Seng Technology ETF (513010) has recorded over 3 billion yuan in net inflows for six consecutive trading days, totaling more than 20 billion yuan [1]. Group 3: Earnings Expectations - According to China Merchants Securities, the fundamentals of the Hong Kong stock market remain solid, with earnings expectations stabilizing [1]. - The EPS forecast for the Hang Seng Technology Index has been continuously adjusted downward since September but has now stabilized, suggesting that current stock prices reflect the market's phase of earnings revision [1].

Core Viewpoint - The pharmaceutical industry is experiencing growth due to persistent human demand and unmet needs, alongside increased R&D investments by companies, marking the transition to an "innovation-driven" revenue era in China [1]. Group 1: Index Performance - The CSI Hong Kong Stock Connect Pharmaceutical and Health Comprehensive Index rose by 2.1% [1]. - The Hang Seng Hong Kong Stock Connect Innovative Drug Index increased by 2.0% [1]. - The CSI Biotechnology Theme Index saw a rise of 0.6% [1]. - The CSI Innovative Drug Industry Index grew by 0.4% [1]. - The CSI 300 Pharmaceutical and Health Index experienced a slight increase of 0.2% [1]. Group 2: Index Composition - The index focuses on leading innovative drug companies in A-shares, comprising no more than 50 stocks involved in innovative drug R&D [5]. - The index tracks leading biotechnology companies in A-shares, including no more than 50 stocks related to gene diagnostics, biopharmaceuticals, and other human biotechnology [7]. - The index covers leading companies in the pharmaceutical and health industry within the CSI 300, including segments like chemical pharmaceuticals, medical services, and medical devices [9]. Group 3: Valuation Metrics - The rolling P/E ratio for the innovative drug index is 50.4 times, with a valuation increase of 72.3% since its inception [6]. - The rolling P/E ratio for the biotechnology index is 53.2 times, with a valuation increase of 58.7% since its inception [8]. - The rolling P/E ratio for the CSI 300 Pharmaceutical and Health Index is 29.9 times, with a valuation increase of 39.2% since its inception [10].

Core Viewpoint - The Hong Kong stock market indices related to healthcare, consumer, and technology sectors have shown positive performance, with significant net inflows into related ETFs, indicating investor confidence in these sectors. Group 1: Index Performance - The CSI Hong Kong Stock Connect Healthcare Index increased by 2.1% [1] - The CSI Hong Kong Stock Connect Consumer Theme Index rose by 1.9% [1] - The CSI Hong Kong Stock Connect Internet Index saw a rise of 1.7% [1] - The Hang Seng Hong Kong Stock Connect New Economy Index increased by 1.5% [1] - The Hang Seng Technology Index rose by 1.3% [1] Group 2: ETF Inflows - The Hong Kong Stock Connect Internet ETF managed by E Fund (513040) experienced a net inflow of 600 million yuan last week [1] - The Hang Seng Technology ETF managed by E Fund (513010) saw a net inflow of 1.8 billion yuan last week [1] Group 3: ETF Details - The Hong Kong Stock Connect New Economy ETF (513320) tracks the Hang Seng Hong Kong Stock Connect New Economy Index, which consists of 50 large-cap stocks in the "new economy" sectors, with a rolling P/E ratio of 23.9 times and a valuation percentile of 47.5% since its inception in 2018 [2] - The Hang Seng Technology ETF (513010) tracks the Hang Seng Technology Index, comprising 30 large-cap stocks related to technology, with a rolling P/E ratio of 22.1 times and a valuation percentile of 23.1% since its launch in 2020 [2] - The Hong Kong Stock Connect Healthcare ETF (513200) tracks the CSI Hong Kong Stock Connect Healthcare Index, consisting of 50 liquid and large-cap stocks in the healthcare sector, with a rolling P/E ratio of 32.3 times and a valuation percentile of 51.2% since its inception in 2017 [2] - The Hong Kong Stock Connect Internet ETF (513040) tracks the CSI Hong Kong Stock Connect Internet Index, which includes 30 leading internet companies, with a rolling P/E ratio of 23.8 times and a valuation percentile of 19.5% since its launch in 2021 [2]

Group 1 - The Hang Seng Hong Kong Stock Connect New Economy Index increased by 1.0%, while the CSI Hong Kong Stock Connect Internet Index rose by 0.8%, the Hang Seng Technology Index by 0.5%, the CSI Hong Kong Stock Connect Consumer Theme Index by 0.3%, and the CSI Hong Kong Stock Connect Healthcare Comprehensive Index by 0.2% [1] - Dongwu Securities indicates that the Hong Kong stock market is in a trend of gradual upward movement, with AI applications expected to accelerate and the semiconductor industry entering a comprehensive price increase phase [1] - Southbound capital flow shows that the information technology sector is one of the main industries for net inflows in the Hong Kong Stock Connect, suggesting a dynamic focus on AI technology in market positioning [1] Group 2 - The E Fund Hong Kong Stock Connect New Economy ETF tracks the Hang Seng Hong Kong Stock Connect New Economy Index, which consists of 50 stocks from the "new economy" sector with the largest market capitalization [2] - The E Fund Hong Kong Stock Connect Technology ETF tracks the Hang Seng Technology Index, comprising 30 stocks highly related to technology, with over 90% of the index made up of information technology and consumer discretionary sectors [2] - The E Fund Hong Kong Stock Connect Healthcare ETF tracks the CSI Hong Kong Stock Connect Healthcare Comprehensive Index, consisting of 50 liquid and large-cap stocks in the healthcare sector, which accounts for over 90% of the index [2] - The E Fund Hong Kong Stock Connect Internet ETF tracks the CSI Hong Kong Stock Connect Internet Index, made up of 30 leading internet companies, primarily in information technology and consumer discretionary sectors [3]